Skip to main content

SC REJECTS NALINI's PITITION

The Supreme Court today dismissed the plea of S Nalini, undergoing life imprisonment in the Rajiv Gandhi assassination case, challenging the law mandating the Centre's approval for her release and that of six other convicts. "Sorry, we are not interested," a bench comprising Chief Justice H L Dattu and justices M B Lokur and A K Sikri said. Nalini had challenged Section 435(1) of the Criminal Procedure Code which mandates the state government to consult the Centre before premature release of a convict if the case was investigated by the CBI. She has been in jail for the last 23 years and undergoing life imprisonment after her death sentence was commuted. She was sentenced to death by the trial court in the case on January 28, 1998. Nalini's death sentence was commuted to life term by the Tamil Nadu Governor on April 24, 2000. "Though 2200 life convicts who had put in less than 10 years of imprisonment were prematurely released by the Tamil Nadu Government during the last about 15 years, she was excluded from consideration for premature release only on the ground that her offence was investigated by the CBI i.e. her case was covered by Section 435(1)(a) CrPC. The said section is unconstitutional," her petition said. The Centre had earlier contended that the Tamil Nadu government can't release the convicts without its approval and had derailed the state government's decision to release them. After the apex court had commuted the death sentence of convicts Murugan, Santhan and Perarivalan, the Tamil Nadu government on February 19 had proposed to remit the sentences of all seven lifers, including the three, and release them.
The decision of the state government to release the convicts was challenged by the Centre before the Supreme Court which had stayed the decision and referred the matter to a Constitution Bench. The court had on February 20 stayed the decision to release of three convicts--Murugan, Santhan and Arivu-- whose death sentence was commuted to life term by it on February 18 in the case, saying there had been procedural lapses on the part of the state government on the decision to release them. The apex court later on had also stayed release of convicts Nalini, Robert Pious, Jayakumar and Ravichandran in the case. Santhan, Murugan and Arivu are currently lodged in the Central Prison, Vellore and they are in jail since 1991. The other four are also undergoing life sentence for their role in Rajiv Gandhi's assassination on May 21, 1991 in Sriperumbudur.
 

Comments

Popular posts from this blog

WORLD'S OLDEST WOMAN

Misao Okawa celebrates her 115th birthday in Osaka, western Japan on March 5, 2013. Okawa was formally recognized as the world's oldest woman.

DEATH...TOUGH TO EXPLAIN FOR KIDS

Illustrating children's books is as challenging as working on books for adults as some images stay with us throughout life even if we may forget the story, says French author and illustrator Olivier Tallec. "Many think children's books are about inspiring stories but there’s a lot more to it. There are books which deal with sensitive issues like death, sexuality, loneliness coupled with humour," Tallec told PTI in an interview. "To illustrate such themes for children's books is very challenging because these concepts are difficult to explain. As an illustrator and writer, I have to be careful about what to say and how to say it to kids because they can be influenced easily," he said. In one of his books "The Scar", Tallec, through a series of illustrations captures the theme of loneliness through the eyes of a child. The story written by Charlotte Moundlic is about a little boy who wakes up to the news of his mother's deat...

B cell- RESPOSE KEY TO FIGHT DIABETES & GUM DESEASE

Modulation of one of the most important blood cells involved in the human immune response may effectively treat and prevent the symptoms of type 2 diabetes and periodontitis simultaneously, scientists say. Researchers have found that B cells, blood cells involved in the human immune response, promote inflammation and bone loss in type 2 diabetes-associated periodontal disease. These findings support the idea that treatments that manipulate the responses of B cells may treat or prevent this complication. "Our study identified common inflammatory mechanisms shared by type 2 diabetes and periodontal disease. It paves the way for the development of novel therapeutics which aim to simultaneously treat both type 2 diabetes and its complications," said Min Zhu, a researcher involved in the work from the department of microbiology at Boston University School of Medicine in Boston, Massachusetts. To make this discovery, scientists used an experimental model (mouse model) of periodo...